O

OrbusNeich Medical Group Holdings Ltd
HKEX:6929

Watchlist Manager
OrbusNeich Medical Group Holdings Ltd
HKEX:6929
Watchlist
Price: 4.1 HKD -1.68% Market Closed
Market Cap: 3.4B HKD
Have any thoughts about
OrbusNeich Medical Group Holdings Ltd?
Write Note

OrbusNeich Medical Group Holdings Ltd
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

OrbusNeich Medical Group Holdings Ltd
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
O
OrbusNeich Medical Group Holdings Ltd
HKEX:6929
Depreciation & Amortization
-$1.1m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Kaisa Health Group Holdings Ltd
HKEX:876
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Kelfred Holdings Ltd
HKEX:1134
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arts Optical International Holdings Ltd
HKEX:1120
Depreciation & Amortization
-HK$4.5m
CAGR 3-Years
-59%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

OrbusNeich Medical Group Holdings Ltd
Glance View

Market Cap
3.4B HKD
Industry
Health Care

OrbusNeich Medical Group Holdings Ltd. operates as an investment holding company. The company employs 880 full-time employees The company went IPO on 2022-12-23. The firm is engaged in the design, development, manufacture, distribution and sale of interventional medical devices for the treatment of coronary heart disease and peripheral vascular diseases. The firm's main products include percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) balloons. In addition, the Company's products also include semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, coronary stents for implantation, non-compliant balloons for post-dilatation and specialty catheters. The firm mainly conducts its businesses in domestic and overseas markets.

Intrinsic Value
4.36 HKD
Undervaluation 6%
Intrinsic Value
Price
O

See Also

What is OrbusNeich Medical Group Holdings Ltd's Depreciation & Amortization?
Depreciation & Amortization
-1.1m USD

Based on the financial report for Dec 31, 2023, OrbusNeich Medical Group Holdings Ltd's Depreciation & Amortization amounts to -1.1m USD.

What is OrbusNeich Medical Group Holdings Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 3Y
12%

Over the last year, the Depreciation & Amortization growth was 6%. The average annual Depreciation & Amortization growth rates for OrbusNeich Medical Group Holdings Ltd have been 12% over the past three years .

Back to Top